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Objective: This article reviews the marked increase in human immunodeficiency virus (HIV) among injection drug 
users (IDU) in Estonia, a former Soviet Union republic bordering the Baltic Sea. HIV infection associated with 
injecting drug use has been reported worldwide. In Eastern Europe large-scale HIV epidemics have been observed 
from 1995 onward, after injection drug use (IDU) communities became infected. 
Materials and Methods: In Estonia, surveillance of HIV infection is based on the mandatory universal notification 
of newly identified cases, with the same reporting principles in use throughout the last decades. By legal regulations 
every sample sent for HIV testing has to be coded (on the testing form) to identify the transmission category it 
belongs to. HIV testing was introduced in Estonia in 1987; by now over 2 million HIV tests have been performed. 
Results: To date since 1987,1305 cases of HIV have reported in Estonia. The incidence of HIV infections remained 
very low until recently, even when a considerable rise occurred in the incidence of sexually transmitted diseases, 
especially syphilis. Through 1999, only 96 cases of HIV had been reported nationally. Since then however, a dramatic 
increase has occurred. The cumulative data, including the information recorded on HIV testing forms and clinical 
records suggest that IDU was a factor in nearly 90% of the new HIV cases reported in year 2000. 
Conclusions: HIV infection appeared in Estonia much later than in many other parts of the world, so the experience 
from other countries that have confronted with the challenges of HIV could be of great help and importance for 
Estonia. The IDU related HIV infection epidemic in Estonia emphasizes an urgent need for preventive measures 
for IDUs as the target group. 
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Human immunodeficiency virus (HIV) and sexually 
transmitted disease (STD) epidemics have had remark- 
able social, demographic, and economic consequences 
in Africa and Asia. More recently, there has been a 
dramatic increase in the reported STD incidence in 
Eastern Europe and Central Asia.l Despite the under- 
reporting of cases and a decline in mass screening, an 
epidemic has been documented.2,3 Besides a rise in the 
STD incidence, increasing rates of HIV and acquired 
immunodeficiency syndrome (AIDS), especially in the 
Russian Federation, have been reported.2 
Injection drug use (IDU) is only one of several 
risks promoting the spread of HIV in Europe. Indeed, 
several countries in Western Europe have reported 
declining HIV incidences among injection drug users 
during the past decade.4 In contrast, the dramatic 
increase in HIV incidence in the countries in Eastern 
Europe and in the Russian Federation can be attributed 
primarily to injection drug use.5,6 
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In the countries in Eastern Europe, economic 
distress, market reforms, and political restructuring 
have had a radical impact on everyday life, as well as a 
negative impact on the health care system.3,7 These con- 
ditions make the communities in those countries partic- 
ularly vulnerable to outbreaks of STDs and HIV.8,9 
This article reviews the marked increase in HIV 
infection among injection drug users in Estonia. 
BACKGROUND AND METHODS 
Estonia is a country in Eastern Europe on the shores of 
the Baltic Sea, that was a Soviet republic until it 
regained its independent statehood in 1991. Estonia is 
the smallest of the three Baltic Republics, covering an 
area of approximately 45,215 square kilometers, with a 
population of approximately 1.4 million people, of 
whom more than two-thirds live in urban areas. Admin- 
istratively, Estonia is divided into 15 counties, the 
smallest with the population of approximately 12,000 
and the largest of 535,000. The second largest, Ida- 
Virumaa county (population 193,610 as of January 1, 
2000) is located at the north-eastern border with the 
Russian Federation; the county’s administrative center 
Narva (population 73,831), is a cross-border town. 
During the first 10 years of independence, a 
decrease in agricultural and industrial production 
occurred, and the economy became more oriented 
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toward provision of services. The role of industrial pro- 
duction declined from 39% to 31% between 1991 and 
1995, and then it became stabilized. Approximately 6% 
of the gross domestic product (GDP) is spent on health 
care (http://www.undp.ee, July 3, 2000).10 The two main 
sources of finance for health care provision in Estonia 
are the health insurance system and the state budget. 
The public health insurance embraces about 90% of 
the Estonian population; it is based on residency, not 
citizenship. 
Basic general statistical data show that the health 
of Estonians has been deteriorating since 1990; the 
death rates attributable to cardiovascular diseases, 
accidents, and poisonings have all risen. In 1994, life 
expectancy was lowest, being for men 61.1 years and for 
women 73.1 years, the former having declined from 66.5 
years and the latter from 74.9 years in 1988.10 However, 
some signs of improvement have been noted in recent 
years. The infant mortality rate that was 15.8 per 1000 
live births in 1993 (having been as low as 12.4 in 1990) 
fell to an all time low of 9.5 in 1999.1° 
Testing for HIV was introduced in Estonia in 1987; 
to date, over 2 million HIV tests have been performed. 
In the early years of HIV testing in Estonia, the cate- 
gories of population to be tested were blood donors 
(765,442 tests), pregnant women (318,330 tests), the 
category of “prophylactic HIV testing” subjects (600,370 
tests). These included hospital inpatients, staff in certain 
occupations (food providers, kindergarten staff, etc.) 
and persons tested on request. The total number of 
HIV tests also includes the tests made for medical indi- 
cations (119,118 tests).The tests for medical indications 
and the tests made for above-mentioned categories 
(blood donors, pregnant women, prophylactic testing) 
constitute 90% of all the tests performed. The remain- 
ing 10% of tests have been done on subjects grouped 
under other transmission categories (Table l).ll The 
total number of tests performed per year was the 
highest in 1990 (269,749 tests). The number fell to about 
80,000 tests per year by 1997, because of changes in the 
screening policy. Currently HIV testing is obligatory 
only for blood donors; pregnant women and prison 
inmates are routinely checked for HIV infection as 
well. For HIV testing, enzyme-linked immunosorbent 
assay (ELISA) kits (Abbott Laboratories, Chicago, IL, 
USA; Ortho Clinical Diagnostics, Ranitan, NJ, USA; 
Bio-Rad Laboratories Inc., Cedex, France) are uni- 
formly used, and results are verified by the immunoblot 
method (Ortho Clinical Diagnostics, BioRad, Inno- 
genetics, Ghent, Belgium). 
In Estonia, surveillance of HIV infection and STDs 
is based on the mandatory universal notification of 
newly identified cases to the State Health Protection 
Service (with the same reporting principles in use 
throughout the past decades). 
By legal regulations, every sample sent for HIV 
testing has to be coded (on the testing form) to identify 
the transmission category to which it belongs. 
RESULTS 
The incidence of syphilis and gonorrhea increased sub- 
stantially during the early 1990s and then it began to 
decline (Figure 1). 3,12 In contrast, there has been an 
increase in the rate of hepatitis B (17.5/100,000 in 1996 
and 34.1/100,000 in 1998) and hepatitis C (6.2/100,000 in 
1996 and 25.3/100,000 in 1998) in recent years (see 
Figure 1).i2 
To date since 1987, 1305 cases of HIV have been 
reported in Estonia (male:female ratio of 914:255) 
(http://www.tervisekaitse.ee/tkuus.php?msgid=415 August 
10, 2001).13 The incidence of HIV infections remained 
low until recently, even when a considerable rise 
occurred in the incidence of sexually transmitted dis- 
Table 1. Testing for Human lmmunodeficiency Virus in Estonia: 1987-2000 
Transmission category* 
HIVpositive 1987-2000 
1987-1999 2000 Total tests HIV-positive 
n=96 fO%Y n=390 (0.46%)# n=2,005,673 (100%) n=486 (100%) 
Sexual contacts of HIV+ 9 
Injection drug users 1 
Patients with STDs 15 
Immigration permit applicants 1 
Women undergoing abortion 2 
Blood donors 6 
Pregnant women 1 
Prisoners 0 
Clinical indications 9 
Anonymous testing 13 
Prophylactic testing 14 
Sailors 17 
Non-Estonian citizens 8 
Othert 0 
(6.52) 
(0.07) 
(0.03) 
IF%; 
(0) 
(0) 
(0) 
(0.01) 
(0.06) 
(0) 
(0.05) 
(0.18) 
(0) 
0 
530 
22 
6 
0 
1 
6 
80 
55 
160 
7 
0 
0 
0 
(0) 
(7.83) 
(1.18) 
(0.70) 
(0) 
(0) 
(0.05) 
(7.44) 
(1.17) 
(4.13) 
(0.06) 
I:; 
(0) 
146 (0.0) 9 (1.9) 
2,138(0.1) 54 (11.1) 
51,432 (2.6) 37 (7.6) 
7,517 (0.4) 7 (1.4) 
13,880 (0.7) 2 (0.4) 
765,442 (38.5) 7 (1.4) 
318,330(15.9) 7 (1.4) 
31,200 (1.6) 80 (16.5) 
119,188 (5.9) 64 (13.2) 
25,359 (1.3) 173 (35.6) 
600,370 (29.9) 21 (4.3) 
35,730 (1.8) 17 (3.5) 
4,520 (0.2) 8 (1.6) 
30,421 (1.5) 0 (0) 
*Identification code of the transmission category of a studied sample marked on every sample sent for HIV testing; trecipients of blood products, army 
recruits, medical personnel; *percentage of total tested within this transmission category; Smore than 1 transmission category code could be marked on 
the HIV test form. 
Drug use was reported for 265 HIV+ persons in 2000. 
eases, especially syphilis. Through 1999, only 96 cases of 
HIV had been reported nationally. Since then however, 
a dramatic increase has occurred: 357 new HIV-positive 
cases were reported during the last 4 months of the year 
2000 and an additional 819 cases during the first 6 
months of 2001 (see Figure 1). The available data on the 
transmission categories of HIV testing identified groups 
at risk, including STD patients, sailors, and the sexual 
contacts of HIV-positive persons.11j14 Now, according to 
the data of 2000, injection drug users have emerged as 
group at risk (http:/“www. tervisekaitse.ee/teatedjastat 
August 10,200l) (see Table 1).11,13,15 
As stipulated by legal regulations, every sample 
sent for HIV testing has to be coded (on the testing 
form) to identify the transmission category of the 
sample.il Before 1999, only one of 96 HIV cases was 
categorized as a user of illicit drugs. According to data 
from testing forms in 2000, 265 (68%) of 390 HIV+ 
tested persons were identified as users of illicit drugs.12 
More than one transmission category code can be indi- 
cated. The “injection drug users” category was mostly 
combined with the “prisoners” or “anonymous testing” 
transmission categories (see Table l)? The cumulative 
data, including the information recorded on HIV testing 
forms and clinical records suggest that IDU was a 
factor in nearly 90% of the new HIV cases reported in 
year 2000.11,13,15 The majority of new HIV cases in the 
years of 2000 and 2001 to date (797/1037,77%), are 
residents in the north-east of Estonia (http://www. 
tervisekaitse.ee/tkuus.php?rnsgid =415 August 10, 2001). 
11,13,15 
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DISCUSSION 
Human immunodeficiency virus infection associated 
with IDU has been reported worldwide and is estab- 
lished as the major cause of rapidly increased rates of 
HIV infection in several countries throughout eastern 
Europe.5,6J6 In the newly independent states of the 
former Soviet Union Republics large-scale HIV epi- 
demics have been observed from 1995 onward, after 
communities of users of illicit drugs became infected.17 
In Estonia a substantial increase of IDU began in 
1994, and it is still on the increase. According to the 
Estonian Health Statistics, the number of patients 
admitted for care for psychiatric and behavioral dis- 
orders caused by the use of illicit drugs has more than 
tripled during the late 1990s (24.5/100,000 in 1995; 
82.2/100,000 in 1998) (http:/narko.sm.ee/LeviWzdevaade. 
asp). Only 10 years ago, procurement of illegal narcotic 
substances in Estonia was difficult if not impossible. 
Older people, whose substance abuse pattern has 
already been established based on consumption of 
alcohol, do not usually reorient themselves to new 
substances. In 1999, Estonia carried out the European 
School Survey Project on Alcohol and Other Drugs 
(ESPAD). According to these results, the share of 
students who have experimented with drugs is almost 
equal in Tallinn and the towns of Ida-Virumaa county. 
Nevertheless, in Tallinn, narcotic substance use tends to 
remain within the limits of recreational consumption 
and club life (rave drugs, amphetamines), but in Ida- 
Virumaa county, the most popular drugs are opiates. In 
Estonia, there are no great ethnic differences related to 
alcoholism. Even so, among the drug addicts admitted 
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Figure 1. Incidence of reported STDs and absolute number of HIV-positive cases in Estonia, 1988-2001. 
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for treatment in 2000, there were 83.2% Russians 
and 11.3% Estonians (http://narko.sm.ee/Levik/2000/ 
default.asp). According to the data from the same data- 
base (drug addicts treatment database) IDU was 
reported by 83.4% of drug addicts, and 84% were 
living either in Tallinn or in Ida-Virumaa county.18 
Unfortunately, no verified data on the extent of drug 
abuse are available, but the number of users of illicit 
drugs in Estonia is estimated to be between 10,000 
and 12,000; the majority are Russian-speaking (90%) 
males, aged 15 to 25 years (85%) who are heroin 
addicts (Kalikova N. Unpublished data).i3*i8 The 
marked increase in HIV incidence in Estonia was 
preceded with an increase in the numbers of registered 
cases of hepatitis B and hepatitis C,12 likely related to 
the spread of IDU in Estonia.13,19,20 The increase may 
also have been caused by a change in the pattern 
of drug use from smoking to injecting drugs.i3 The 
affected patients are young: in the 1994 to 1997 period 
there has been an almost fivefold increase in the 
absolute numbers of the registered new cases of 
hepatitis B and C in the age group 15 to 19 years; 50% 
of hepatitis B and 52% of hepatitis C cases were diag- 
nosed in this age group in year 1997 (http://www.sm.ee/ 
s<at/htmZ August 10,200l). 
A study from Estonia by Priimagi and co-workers 
showed that of the 57 intravenous drug users under 
study, serologic markers of hepatitis B were detected in 
79% and, of hepatitis C, in 83% of cases.19 The inci- 
dence of reported new cases of hepatitis B and C is the 
highest in the north-east of Estonia and in Tallinn, the 
capital city. 21 Whereas in the year 2000, the incidence 
of hepatitis B was 30.1 and hepatitis C was 20.1 per 
100,000 for the whole of Estonia, in the Ida-Virumaa 
county, in the north east, it was 122.8 and 76.4, and in 
Tallinn, 41.7 and 40.7.12 These two regions are also 
known to have the worst illegal drug problems in 
Estonia. 
Social and economic factors are important in the 
development of risk environments conducive to HIV 
and epidemic spread.8 A growing admission of the role 
of social and economic factors in STD and HIV spread 
is the focus of the STDs prevention strategies that place 
a great emphasis on the social and structural interven- 
tions that require joint efforts from the health sector 
and other community resources.22 Economic distress is 
known to be accompanied by an increase of poverty 
and unemployment. Employment in Estonia decreased 
by 23% in 1989-1998, according to labor market studies. 
As segmentary territorial labor division was the rule 
during the Soviet period in Estonia’s history, social 
problems are different in different parts of Estonia. 
Unemployment is a great problem in the Ida-Virumaa 
county because of the high concentration of the former 
centrally controlled Soviet enterprises in that county.23 
The inhabitants in Ida-Virumaa county (bordering on 
Russia) mostly work in those branches of economy 
(e.g., machine building and metal working), which have 
reduced their production following the restoration of 
Estonia’s independence, since they cannot use the same 
capacities of raw material or marketing opportunities 
they had been offered in the Soviet Union. The so- 
called underground economies, including those associ- 
ated with crime and drugs, have grown because they can 
draw their labor force from among the unemployed and 
the poor. As shown by the official statistical data, crime 
was highest in Narva and its vicinity; crime was also 
high in Tallinn, the capital of the Republic of Estonia 
(http://www.stat.vil.ee/pks/kuritegevus/crime/sisu/html 
January 29,200l). Free migration and mixing of people 
is probably one of the key factors in HIV infection out- 
breaks. Major motorways may serve as conduits for 
illegal drug trafficking. Drugs are known to have a 
potential of altering sexual mixing patterns.24 Narva is 
located on the route of transport from Russia to 
Estonia not far from St. Petersburg. Importantly, the 
Russian Federation also has reported a loo-fold 
increase in the number of new HIV cases between 1996 
and 1998, with most cases diagnosed in the large urban 
centers of Moscow and St. Petersburg.7 While in the 
year 1998, the incidence of syphilis for the whole terri- 
tory of Estonia was 75.7 per 100,000 of population, the 
syphilis incidence (258.8/100,000 population) in Narva 
was of a similar magnitude as the syphilis incidence in 
the Russian Federation in 1998 (234/100,000 popula- 
tion).12,25 
One of the interesting observations from the last 
decade of the twentieth century in Estonia is that 
the number of cases of HIV infection initially remained 
relatively low, in spite of the rapidly and substantially 
increasing STD rates (syphilis in particular) (see Figure 
1). The epidemic of HIV began to develop only after it 
was introduced to the drug injecting community. 
Infection with HIV appeared in Estonia much later 
than in many other parts of the world, so the experience 
from other countries that have been confronted with 
the challenges of HIV could be of great help and 
importance for Estonia. The IDU-related HIV infection 
epidemic in Estonia emphasizes an urgent need for 
preventive measures for users of injection drugs. These 
measures may include syringe needle exchange and 
distribution programs, substitution pharmacotherapy, 
condom distribution, outreach to drug users, and peer 
education programs. Failure to act now will result in an 
even more dramatic and widespread HIV epidemic in 
Estonia. 
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